Last Updated: June 22, 2026

Details for New Drug Application (NDA): 018677

✉ Email this page to a colleague

NDA 018677 describes CESAMET, which is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. Additional details are available on the CESAMET profile page.

The generic ingredient in CESAMET is nabilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nabilone profile page.

Summary for 018677

Tradename:	CESAMET
Applicant:	Bausch
Ingredient:	nabilone
Patents:	0

Pharmacology for NDA: 018677

Suppliers and Packaging for NDA: 018677

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CESAMET	nabilone	CAPSULE;ORAL	018677	NDA	Bausch Health US LLC	0187-1231	0187-1231-50	1 BOTTLE in 1 CARTON (0187-1231-50) / 50 CAPSULE in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	CAPSULE;ORAL			Strength	1MG
Approval Date:	Dec 26, 1985	TE:		RLD:	Yes

Expired US Patents for NDA 018677

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	4,087,547	⤷ Start Trial
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	3,920,809	⤷ Start Trial
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	4,087,545	⤷ Start Trial
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	3,928,598	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.